Name:	O
___	O
Unit	O
No:	O
___	O
Admission	O
Date:	O
___	O
Discharge	O
Date:	O
___	O
Date	O
of	O
Birth:	O
___	O
Sex:	O
M	O
Service:	O
CARDIOTHORACIC	O
Allergies:	O
Penicillins	O
Attending:	O
___	O
Chief	O
Complaint:	O
hypotension	O
during	O
ambulance	O
transfer	O
Major	O
Surgical	O
or	O
Invasive	O
Procedure:	O
none	O
History	O
of	O
Present	O
Illness:	O
___	O
yo	O
male	O
known	O
to	O
our	O
service.	O
Discharged	O
to	O
rehab	O
on	O
___	O
after	O
redo	O
cabg	O
x4.	O
Failure	O
to	O
thrive	O
at	O
rehab	O
and	O
was	O
being	O
transferred	O
to	O
another	O
rehab	O
facility	O
when	O
he	O
became	O
hypotensive	O
in	O
the	O
ambulance.	O
BP	O
in	O
___.	O
Poor	O
po	O
intake	O
recently,	O
and	O
developed	O
a	O
cough.	O
He	O
was	O
complaining	O
of	O
abdominal	O
pain	O
and	O
an	O
outside	O
CT	O
scan	O
showed	O
splenic	O
infarct.Transferred	O
here	O
for	O
further	O
evaluation.	O
Past	O
Medical	O
History:	O
Coronary	O
Artery	O
Disease	O
with	O
histoy	O
of	O
myocardial	O
infarction	O
___	O
and	O
coronary	O
artery	O
bypass	O
surgery	O
___	O
REDO	O
CABG	O
x4	O
___	O
Diabetes	O
Mellitus	O
Hypertension	O
Chronic	O
atrial	O
fibrillation	O
and	O
right	O
bundle	O
branch	O
block	O
Acute	O
on	O
chronic	O
renal	O
failure	O
Transient	O
ischemia	O
attack	O
___	O
Status	O
post	O
Cholecystectomy	O
Chronic	O
thrombocytopenia	O
Social	O
History:	O
___	O
Family	O
History:	O
Multiple	O
family	O
members	O
with	O
CAD	O
Physical	O
Exam:	O
HR	O
76	O
irregular	O
RR	O
15	O
O2	O
sat	O
100%	O
110/65	O
68"	O
77	O
kg	O
EOMI	O
skin	O
dry	O
neck	O
with	O
full	O
ROM	O
CTAB	O
___	O
no	O
murmur	O
soft,	O
distended,	O
non-tender	O
+	O
BS	O
warm	O
extrems	O
2+	O
pitting	O
edema	O
BLE	O
neuro	O
grossly	O
intact	O
fem	O
pulses	O
present	O
radial	O
pulses	O
present	O
no	O
carotid	O
bruits	O
Pertinent	O
Results:	O
Conclusions	O
There	O
is	O
mild	O
symmetric	O
left	O
ventricular	O
hypertrophy.	O
The	O
left	O
ventricular	O
cavity	O
size	O
is	O
normal.	O
Overall	O
left	O
ventricular	O
systolic	O
function	O
is	O
low	O
normal	O
(LVEF	O
50%)	O
secondary	O
to	O
hypokinesis	O
of	O
the	O
septum,	O
anterior	O
free	O
wall,	O
and	O
apex;	O
the	O
rest	O
of	O
the	O
left	O
ventricle	O
is	O
hyperdynamic.	O
Right	O
ventricular	O
chamber	O
size	O
is	O
normal.	O
with	O
depressed	O
free	O
wall	O
contractility.	O
There	O
are	O
three	O
aortic	O
valve	O
leaflets.	O
The	O
aortic	O
valve	O
leaflets	O
are	O
moderately	O
thickened.	O
Significant	O
aortic	O
stenosis	O
is	O
present	O
(not	O
quantified).	O
No	O
aortic	O
regurgitation	O
is	O
seen.	O
The	O
mitral	O
valve	O
leaflets	O
are	O
mildly	O
thickened.	O
There	O
is	O
no	O
mitral	O
valve	O
prolapse.	O
Trivial	O
mitral	O
regurgitation	O
is	O
seen.	O
[Due	O
to	O
acoustic	O
shadowing,	O
the	O
severity	O
of	O
mitral	O
regurgitation	O
may	O
be	O
significantly	O
UNDERestimated.]	O
There	O
is	O
a	O
trivial/physiologic	O
pericardial	O
effusion.	O
There	O
are	O
no	O
echocardiographic	O
signs	O
of	O
tamponade.	O
Electronically	O
signed	O
by	O
___,	O
MD,	O
Interpreting	O
physician	O
___	O
___	O
09:29	O
CT	O
OF	O
THE	O
ABDOMEN	O
:	O
Moderate	O
bilateral	O
pleural	O
effusions	O
are	O
noted	O
at	O
the	O
lung	O
bases.	O
There	O
are	O
severe	O
atelectatic	O
changes	O
of	O
the	O
left	O
lower	O
lobe	O
and	O
part	O
of	O
right	O
lower	O
lobe	O
and	O
right	O
middle	O
lobe.	O
Coronary	O
artery	O
calcification	O
and	O
aortic	O
calcification	O
are	O
also	O
noted.	O
The	O
heart	O
size	O
is	O
moderately	O
enlarged.	O
The	O
liver	O
is	O
normal.	O
The	O
gallbladder	O
is	O
not	O
visualized.	O
The	O
spleen	O
is	O
enlarged.	O
The	O
spleen	O
contains	O
a	O
wedge-shaped	O
peripheral	O
hypodense	O
area,	O
which	O
based	O
on	O
its	O
shape	O
might	O
represent	O
splenic	O
infarction.	O
Without	O
IV	O
contrast,	O
this	O
appearance	O
is	O
highly	O
nonspecific.	O
The	O
left	O
kidney	O
contains	O
simple	O
cysts	O
within	O
its	O
mid	O
pole	O
measuring	O
approximately	O
2.3	O
and	O
3.8	O
cm.	O
The	O
right	O
kidney	O
contains	O
a	O
5-mm	O
hyperdense	O
cyst	O
and	O
3mm	O
of	O
calcification	O
which	O
might	O
represent	O
stone	O
or	O
calcified	O
artery.	O
The	O
adrenal	O
glands	O
have	O
normal	O
appearance.	O
The	O
pancreas,	O
common	O
bile	O
duct,	O
stomach,	O
duodenum,	O
and	O
loops	O
of	O
small	O
bowel	O
and	O
large	O
bowel	O
are	O
normal.	O
Small	O
amount	O
of	O
free	O
fluid	O
is	O
noted	O
within	O
the	O
pelvis.	O
CT	O
OF	O
THE	O
PELVIS:	O
The	O
rectum	O
and	O
sigmoid	O
colon	O
have	O
normal	O
appearance.	O
Urinary	O
bladder	O
contains	O
a	O
Foley	O
catheter	O
and	O
the	O
prostate	O
gland	O
is	O
mildly	O
enlarged.	O
No	O
free	O
air	O
is	O
noted	O
within	O
the	O
abdomen	O
and	O
pelvis.	O
No	O
pathologically	O
enlarged	O
nodes	O
are	O
visualized.	O
Diffuse	O
soft	O
tissue	O
fluid	O
accumulation	O
is	O
compatible	O
with	O
anasarca.	O
BONE	O
WINDOWS:	O
No	O
concerning	O
lytic	O
or	O
sclerotic	O
lesions	O
are	O
identified.	O
IMPRESSION:	O
1.	O
Moderate	O
bibasilar	O
pleural	O
effusion	O
and	O
bibasilar	O
atelectatic	O
changes	O
at	O
the	O
lung	O
bases.	O
2.	O
Splenomegaly.	O
Wedge-shaped	O
hypodense	O
lesion	O
of	O
the	O
superior	O
pole	O
of	O
the	O
spleen	O
most	O
likely	O
represents	O
an	O
infarct	O
based	O
on	O
morphology.	O
However,	O
without	O
IV	O
contrast,	O
further	O
characterization	O
is	O
not	O
possible	O
and	O
this	O
appearance	O
is	O
highly	O
nonspecific.	O
If	O
indicated,	O
consider	O
repeat	O
study	O
with	O
IV	O
contrast.	O
3.	O
Small	O
amount	O
of	O
free	O
fluid	O
is	O
noted	O
within	O
the	O
pelvis.	O
4.	O
Two	O
simple	O
cysts	O
are	O
noted	O
in	O
the	O
mid	O
pole	O
and	O
lower	O
pole	O
of	O
the	O
left	O
kidney.	O
5.	O
Anasarca.	O
The	O
study	O
and	O
the	O
report	O
were	O
reviewed	O
by	O
the	O
staff	O
radiologist.	O
___.	O
___	O
___.	O
___	O
___:	O
FRI	O
___	O
12:45	O
AM	O
Brief	O
Hospital	O
Course:	O
___	O
was	O
admitted	O
___	O
for	O
hypotension,	O
renal	O
insufficiency	O
with	O
volume	O
overload,	O
and	O
abdominal	O
discomfort.	O
A	O
CT	O
scan	O
of	O
his	O
abdominal	O
showed	O
anasarca,	O
questionable	O
splenic	O
infarct.	O
Admission	O
creatinine	O
was	O
2.7	O
in	O
a	O
hemolyzed	O
specimen;	O
repeat	O
was	O
2.0.	O
Echo	O
was	O
performed	O
to	O
evaluate	O
tamponade.	O
No	O
pericardial	O
effusion	O
evident.	O
Coumadin	O
held	O
and	O
gentle	O
diuresis	O
continued	O
over	O
the	O
next	O
several	O
days.	O
Coumadin	O
restarted	O
___.	O
Beta	O
blockade	O
titrated.	O
Respiratory	O
status	O
improved	O
and	O
creatinine	O
continued	O
to	O
decrease.	O
___	O
consulted	O
and	O
recommended	O
continuing	O
januvia	O
and	O
starting	O
lantus.	O
Mr.	O
___	O
continued	O
to	O
progress	O
and	O
___	O
him	O
for	O
discharge	O
to	O
rehab	O
on	O
HD#6.	O
All	O
follow	O
up	O
appointments	O
were	O
advised.	O
Medications	O
on	O
Admission:	O
1.	O
Acetaminophen	O
325	O
mg	O
Tablet	O
Sig:	O
Two	O
(2)	O
Tablet	O
PO	O
Q4H	O
(every	O
4	O
hours)	O
as	O
needed	O
for	O
temperature	O
>38.0.	O
2.	O
Aspirin	O
81	O
mg	O
Tablet,	O
Delayed	O
Release	O
(E.C.)	O
Sig:	O
One	O
(1)	O
Tablet,	O
Delayed	O
Release	O
(E.C.)	O
PO	O
DAILY	O
(Daily).	O
3.	O
Ranitidine	O
HCl	O
150	O
mg	O
Tablet	O
Sig:	O
One	O
(1)	O
Tablet	O
PO	O
DAILY	O
(Daily).	O
4.	O
Docusate	O
Sodium	O
100	O
mg	O
Capsule	O
Sig:	O
One	O
(1)	O
Capsule	O
PO	O
BID	O
(2	O
times	O
a	O
day).	O
5.	O
Magnesium	O
Hydroxide	O
400	O
mg/5	O
mL	O
Suspension	O
Sig:	O
Thirty	O
(30)	O
ML	O
PO	O
DAILY	O
(Daily)	O
as	O
needed	O
for	O
constipation.	B-Constipation
6.	O
Sodium	O
Chloride	O
0.65	O
%	O
Aerosol,	O
Spray	O
Sig:	O
___	O
Sprays	O
Nasal	O
QID	O
(4	O
times	O
a	O
day)	O
as	O
needed.	O
7.	O
Atorvastatin	O
10	O
mg	O
Tablet	O
Sig:	O
One	O
(1)	O
Tablet	O
PO	O
DAILY	O
(Daily):	O
needs	O
follow	O
up	O
LFT's	O
in	O
one	O
month.	O
8.	O
Tramadol	O
50	O
mg	O
Tablet	O
Sig:	O
One	O
(1)	O
Tablet	O
PO	O
Q6H	O
(every	O
6	O
hours)	O
as	O
needed.	O
9.	O
Glyburide	O
2.5	O
mg	O
Tablet	O
Sig:	O
One	O
(1)	O
Tablet	O
PO	O
BID	O
(2	O
times	O
a	O
day).	O
10.	O
Warfarin	O
1	O
mg	O
Tablet	O
Sig:	O
as	O
directed	O
Tablet	O
PO	O
DAILY	O
(Daily)	O
as	O
needed	O
for	O
atrial	O
fibrillation	O
:	O
INR	O
goal	O
___	O
rec'd	O
2.5	O
mg	O
___.	O
11.	O
Bisacodyl	O
5	O
mg	O
Tablet,	O
Delayed	O
Release	O
(E.C.)	O
Sig:	O
Two	O
(2)	O
Tablet,	O
Delayed	O
Release	O
(E.C.)	O
PO	O
DAILY	O
(Daily)	O
as	O
needed.	O
12.	O
Lisinopril	O
5	O
mg	O
Tablet	O
Sig:	O
0.5	O
Tablet	O
PO	O
DAILY	O
(Daily).	O
13.	O
Levalbuterol	O
HCl	O
0.63	O
mg/3	O
mL	O
Solution	O
for	O
Nebulization	O
Sig:	O
One	O
(1)	O
ML	O
Inhalation	O
TID	O
().	O
14.	O
Metoprolol	O
Succinate	O
100	O
mg	O
Tablet	O
Sustained	O
Release	O
24	O
hr	O
Sig:	O
One	O
(1)	O
Tablet	O
Sustained	O
Release	O
24	O
hr	O
PO	O
DAILY	O
(Daily).	O
15.	O
Tamsulosin	O
0.4	O
mg	O
Capsule,	O
Sust.	O
Release	O
24	O
hr	O
Sig:	O
One	O
(1)	O
Capsule,	O
Sust.	O
Release	O
24	O
hr	O
PO	O
HS	O
(at	O
bedtime).	O
16.	O
Lasix	O
20	O
mg	O
Tablet	O
Sig:	O
One	O
(1)	O
Tablet	O
PO	O
twice	O
a	O
day	O
for	O
7	O
days:	O
then	O
decrease	O
to	O
20mg	O
daily	O
ongoing.	O
Discharge	O
Medications:	O
1.	O
Sitagliptin	O
100	O
mg	O
Tablet	O
Sig:	O
One	O
(1)	O
Tablet	O
PO	O
daily	O
().	O
Disp:*30	O
Tablet(s)*	O
Refills:*2*	O
2.	O
Acetaminophen	O
325	O
mg	O
Tablet	O
Sig:	O
Two	O
(2)	O
Tablet	O
PO	O
Q6H	O
(every	O
6	O
hours)	O
as	O
needed	O
for	O
pain.	O
3.	O
Aspirin	O
81	O
mg	O
Tablet,	O
Chewable	O
Sig:	O
One	O
(1)	O
Tablet,	O
Chewable	O
PO	O
DAILY	O
(Daily).	O
4.	O
Docusate	O
Sodium	O
100	O
mg	O
Capsule	O
Sig:	O
One	O
(1)	O
Capsule	O
PO	O
BID	O
(2	O
times	O
a	O
day)	O
as	O
needed	O
for	O
constipation.	B-Constipation
5.	O
Atorvastatin	O
10	O
mg	O
Tablet	O
Sig:	O
One	O
(1)	O
Tablet	O
PO	O
DAILY	O
(Daily).	O
6.	O
Tamsulosin	O
0.4	O
mg	O
Capsule,	O
Sust.	O
Release	O
24	O
hr	O
Sig:	O
One	O
(1)	O
Capsule,	O
Sust.	O
Release	O
24	O
hr	O
PO	O
HS	O
(at	O
bedtime).	O
7.	O
Pantoprazole	O
40	O
mg	O
Tablet,	O
Delayed	O
Release	O
(E.C.)	O
Sig:	O
One	O
(1)	O
Tablet,	O
Delayed	O
Release	O
(E.C.)	O
PO	O
Q24H	O
(every	O
24	O
hours).	O
8.	O
Warfarin	O
1	O
mg	O
Tablet	O
Sig:	O
per	O
MD	O
order	O
___	O
PO	O
___	O
Daily	O
at	O
4	O
___.	O
9.	O
Tramadol	O
50	O
mg	O
Tablet	O
Sig:	O
One	O
(1)	O
Tablet	O
PO	O
BID	O
(2	O
times	O
a	O
day)	O
as	O
needed	O
for	O
pain.	O
10.	O
Metoprolol	O
Succinate	O
100	O
mg	O
Tablet	O
Sustained	O
Release	O
24	O
hr	O
Sig:	O
One	O
(1)	O
Tablet	O
Sustained	O
Release	O
24	O
hr	O
PO	O
DAILY	O
(Daily).	O
11.	O
Magnesium	O
Hydroxide	O
400	O
mg/5	O
mL	O
Suspension	O
Sig:	O
Thirty	O
(30)	O
ML	O
PO	O
Q6H	O
(every	O
6	O
hours)	O
as	O
needed	O
for	O
constipation.	B-Constipation
12.	O
Insulin	O
Aspart	O
100	O
unit/mL	O
Cartridge	O
Sig:	O
One	O
(1)	O
Subcutaneous	O
ACHS.	O
13.	O
Sodium	O
Chloride	O
0.9	O
%	O
0.9	O
%	O
Syringe	O
Sig:	O
One	O
(1)	O
ML	O
Injection	O
Q8H	O
(every	O
8	O
hours)	O
as	O
needed	O
for	O
line	O
flush.	O
14.	O
Furosemide	O
40	O
mg	O
Tablet	O
Sig:	O
One	O
(1)	O
Tablet	O
PO	O
three	O
times	O
a	O
day.	O
15.	O
Potassium	O
Chloride	O
20	O
mEq	O
Tab	O
Sust.Rel.	O
Particle/Crystal	O
Sig:	O
One	O
(1)	O
Tab	O
Sust.Rel.	O
Particle/Crystal	O
PO	O
every	O
twelve	O
(12)	O
hours.	O
16.	O
Warfarin	O
1	O
mg	O
Tablet	O
Sig:	O
Five	O
(5)	O
Tablet	O
PO	O
ONCE	O
(Once)	O
for	O
1	O
doses:	O
tonight	O
___.	O
17.	O
Nystatin	O
100,000	O
unit/mL	O
Suspension	O
Sig:	O
One	O
(1)	O
PO	O
QID	O
prn.	O
Discharge	O
Disposition:	O
Extended	O
Care	O
Facility:	O
___	O
Discharge	O
Diagnosis:	O
Coronary	O
Artery	O
Disease	O
s/p	O
redo	O
CABG	O
x4	O
___	O
Myocardial	O
Infarction	O
acute	O
on	O
chronic	O
Systolic	O
Congestive	O
heart	O
failure	O
Pneumonia	B-Lower_respiratory_tract_infection
status	O
post	O
Coronary	O
artery	O
bypass	O
graft	O
___	O
Chronic	O
atrial	O
fibrillation	O
and	O
right	O
bundle	O
branch	O
block	O
Diabetes	O
Mellitus	O
Acute	O
on	O
chronic	O
renal	O
failure	O
Transient	O
ischemia	O
attack	O
___	O
Chronic	O
thrombocytopenia	O
Discharge	O
Condition:	O
stable	O
Discharge	O
Instructions:	O
Please	O
shower	O
daily	O
including	O
washing	O
incisions,	O
no	O
baths	O
or	O
swimming	O
Monitor	O
wounds	O
for	O
infection	O
-	O
redness,	O
drainage,	O
or	O
increased	O
pain	O
Report	O
any	O
fever	O
greater	O
than	O
101	O
Report	O
any	O
weight	O
gain	O
of	O
greater	O
than	O
2	O
pounds	O
in	O
24	O
hours	O
or	O
5	O
pounds	O
in	O
a	O
week	O
No	O
creams,	O
lotions,	O
powders,	O
or	O
ointments	O
to	O
incisions	O
No	O
driving	O
for	O
approximately	O
one	O
month	O
AND	O
while	O
while	O
taking	O
narcotics	O
No	O
lifting	O
more	O
than	O
10	O
pounds	O
for	O
10	O
weeks	O
from	O
date	O
of	O
surgery	O
Please	O
call	O
with	O
any	O
questions	O
or	O
concerns	O
___	O
Followup	O
Instructions:	O
___	O

